Brief: Guangzhou Innogen Pharmaceutical Expects RMB341.4 Million Loss For Year
18/03/2026 10:53
March 18 (Reuters) - Guangzhou Innogen Pharmaceutical Group Co Ltd 2591.HK: EXPECTS RMB341.4 MILLION LOSS FOR YEAR EXPECTED FY RESULTS DUE TO INCREASE IN RESEARCH & DEVELOPMENT EXPENSES OF RMB103.3 MILLION, OTHERS Further company coverage: 2591.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guangzhou Innogen Pharmaceutical
See all newsBrief: Guangzhou Innogen Pharmaceutical Appoints Jin Bai As Vice President
Brief: Guangzhou Innogen Pharmaceutical Says Xu Wenjie Resigns As Executive Director
Brief: Guangzhou Innogen Pharmaceutical Group Co's Founder, Senior Management Undertakes Six-Month Lock-Up
Brief: Guangzhou Innogen Pharmaceutical Announces Intention To Conduct On-Market H Share Repurchase
Brief: GUANGZHOU INNOGEN PHARMACEUTICAL Posts HY LOSS Of RMB115.5 MLN